Literature DB >> 9508314

A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies.

D D'Antonio1, B Violante, A Mazzoni, T Bonfini, M A Capuani, F D'Aloia, A Iacone, F Schioppa, F Romano.   

Abstract

Candida inconspicua was recovered from three patients with hematological malignancies. Two patients had intravenous-catheter-associated fungemia, whereas the third had fungal hepatitis. The three cases of infection occurred over a period of 1 month in patients staying in adjacent single rooms. In vitro susceptibility testing of fungal strains showed all isolates to be resistant to fluconazole, with MICs greater than 32 microg/ml. All of the strains had identical DNA restriction profiles and randomly amplified polymorphic DNA fingerprints. These data suggest a nosocomially acquired infection emanating from a common source within the hospital environment.

Entities:  

Mesh:

Year:  1998        PMID: 9508314      PMCID: PMC104627          DOI: 10.1128/JCM.36.3.792-795.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  [Topical one-time therapy with ketoconazole: a double-blind randomized study in vaginal mycosis].

Authors:  I Gerhard; D Ohlhorst; W Eggert-Kruse; B Runnebaum
Journal:  Mycoses       Date:  1989-05       Impact factor: 4.377

3.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Risk factors for candidemia in cancer patients: a case-control study.

Authors:  A Karabinis; C Hill; B Leclercq; C Tancrède; D Baume; A Andremont
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

Review 5.  Infectious complications in leukemic patients.

Authors:  G P Bodey; R Bolivar; V Fainstein
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

6.  Chronic atrophic oral candidiasis among patients with diabetes mellitus--role of secretor status.

Authors:  F Z Aly; C C Blackwell; D A MacKenzie; D M Weir; R A Elton; C G Cumming; J A Sofaer; B F Clarke
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

7.  Candidemia in immunocompromised patients.

Authors:  F Meunier; M Aoun; N Bitar
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

8.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

Review 9.  Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.

Authors:  M Thaler; B Pastakia; T H Shawker; T O'Leary; P A Pizzo
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

10.  Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.

Authors:  A Chubachi; I Miura; A Ohshima; T Nishinari; T Nimura; H Niitsu; A B Miura
Journal:  Am J Med Sci       Date:  1994-12       Impact factor: 2.378

View more
  11 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Primers ITS1, ITS2 and ITS4 detect the intraspecies variability in the internal transcribed spacers and 5.8S rRNA gene region in clinical isolates of fungi.

Authors:  M Korabecná; V Liska; K Fajfrlík
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 4.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

5.  Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.

Authors:  F Marco; S R Lockhart; M A Pfaller; C Pujol; M S Rangel-Frausto; T Wiblin; H M Blumberg; J E Edwards; W Jarvis; L Saiman; J E Patterson; M G Rinaldi; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation.

Authors:  Domenico D'Antonio; Ferdinando Romano; Eugenio Pontieri; Giuseppe Fioritoni; Claudia Caracciolo; Stefano Bianchini; Paola Olioso; Tommaso Staniscia; Roberta Sferra; Stefania Boccia; Antonella Vetuschi; Giovanni Federico; Eugenio Gaudio; Giuseppe Carruba
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients.

Authors:  H Agirbasli; S A Keceli Ozcan; Gündüz Gedikoğlu
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

8.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; D Ellis; V Tullio; A Rodloff; W Fu; T A Ling
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

9.  Nosocomial cluster of Candida guillermondii fungemia in surgical patients.

Authors:  L Masala; R Luzzati; L Maccacaro; L Antozzi; E Concia; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

10.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.